ScholarIQanswers from OpenAlex

Rapamycin treatment for amyotrophic lateral sclerosis

PaperCitations, authors & open-access status

Rapamycin treatment for amyotrophic lateral sclerosis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Rapamycin treatment for amyotrophic lateral sclerosis have?

ScholarIQcitation count

Rapamycin treatment for amyotrophic lateral sclerosis has 128 citations in the OpenAlex counts ScholarIQ stores.

When was Rapamycin treatment for amyotrophic lateral sclerosis published?

ScholarIQyear

Rapamycin treatment for amyotrophic lateral sclerosis has 2018 year in the ScholarIQ index.

What is the open-access status of Rapamycin treatment for amyotrophic lateral sclerosis?

ScholarIQoa status

Rapamycin treatment for amyotrophic lateral sclerosis has gold oa status in the ScholarIQ index.

What is the DOI of Rapamycin treatment for amyotrophic lateral sclerosis?

ScholarIQdoi

The DOI for Rapamycin treatment for amyotrophic lateral sclerosis is on the source record.

What is the PMID of Rapamycin treatment for amyotrophic lateral sclerosis?

ScholarIQpmid

The PMID for Rapamycin treatment for amyotrophic lateral sclerosis is on the source record.

What is the OpenAlex record for Rapamycin treatment for amyotrophic lateral sclerosis?

ScholarIQopenalex

The OpenAlex for Rapamycin treatment for amyotrophic lateral sclerosis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial